Trump administration to announce Tylenol may increase autism risk during pregnancy

On Monday, September 22, 2025, the Trump administration is expected to announce findings suggesting that taking Tylenol during pregnancy may increase the risk of autism in children. This announcement is anticipated to raise significant public health concerns regarding the use of acetaminophen, the active ingredient in Tylenol, among pregnant individuals.

The potential link between Tylenol and autism has been a topic of ongoing research, and this forthcoming statement from the administration is likely to draw attention from health officials and expectant parents alike. As previously reported, discussions surrounding medication safety during pregnancy have become increasingly prominent in recent years.

This announcement follows a broader trend of scrutiny regarding pharmaceutical use during pregnancy, reflecting growing concerns about the implications of various medications on fetal development. The administration"s statement is expected to provide further details on the findings and recommendations regarding Tylenol use.

For more information on related coverage, see recent developments in health and safety discussions.

Image for Trump administration to announce Tylenol may increase autism risk during pregnancy